Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 21.25
+0.39 (1.87%)
Aug 4, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 4.29 billion as of August 4, 2026. Its market cap has decreased by -13.71% in one year.
Market Cap
4.29B
Enterprise Value
4.03B
Revenue
1.74B
Ranking
n/a
PE Ratio
15.00
Stock Price
21.25
ChartMarket Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 4.29B, a decrease of -37.26%. That is a compound annual growth rate of -7.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.29B | 2.61% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 4.69B |
| Suzhou Fengbei Biotech Stock | 4.67B |
| Xiangxue Pharmaceutical | 4.62B |
| R&G PharmaStudies | 4.53B |
| Shenzhen Weiguang Biological Products | 4.52B |
| ChemPartner PharmaTech | 4.46B |
| PharmaResources (Shanghai) | 4.37B |
| Anhui Huaheng Biotechnology | 4.24B |